Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Sep;37(3):1261–1269. doi: 10.1128/iai.37.3.1261-1269.1982

Protective effect of glucan against visceral leishmaniasis in hamsters.

J A Cook, T W Holbrook, W J Dougherty
PMCID: PMC347673  PMID: 7129637

Abstract

The effect of pre- or posttreatment with glucan, a reticuloendothelial stimulant, on the course of Leishmania donovani infection was assessed in highly susceptible hamsters. Intravenous administration of glucan before or after L. donovani infection significantly suppressed proliferation of amastigote-stage parasites in liver and spleen. Glucan-activated peritoneal macrophages in vitro also significantly reduced multiplication of the intracellular parasite. Ultrastructural studies revealed a well-defined hepatic granulomatous response to glucan, with hypertrophic Kupffer cells and reduced numbers of intracellular parasites compared to the control group. In additional studies, groups of hamsters were immunized by intravenous injections of glucan with Formalin-killed promastigote-stage L. donovani cells and challenged 60 days after the last immunizing injection. This treatment regimen significantly prolonged the mean survival time of those hamsters which died after infection, relative to untreated control groups. Hamsters stimulated with the glucan-killed promastigote preparation also exhibited significant reductions in splenic amastigotes on days 10 and 21 postinfection compared with all other control groups, but on day 35, splenic amastigotes did not differ significantly from those of control animals. Our composite observations provide evidence for glucan-enhanced nonspecific resistance of hamsters to visceral leishmaniasis.

Full text

PDF
1261

Images in this article

1264Image
on p.1264
1265Image
on p.1265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchmüller Y., Mauel J. Studies on the mechanisms of macrophage activation: possible involvement of oxygen metabolites in killing of Leishmania enrietti by activated mouse macrophages. J Reticuloendothel Soc. 1981 Mar;29(3):181–192. [PubMed] [Google Scholar]
  2. Burgaleta C., Golde D. W. Effect of glucan on granulopoiesis and macrophage genesis in mice. Cancer Res. 1977 Jun;37(6):1739–1742. [PubMed] [Google Scholar]
  3. Cook J. A., Holbrook T. W., Parker B. W. Visceral leishmaniasis in mice: protective effect of glucan. J Reticuloendothel Soc. 1980 Jun;27(6):567–573. [PubMed] [Google Scholar]
  4. Deimann W., Fahimi H. D. The appearance of transition forms between monocytes and Kupffer cells in the liver of rats treated with glucan. A cytochemical and ultrastructural study. J Exp Med. 1979 Apr 1;149(4):883–897. doi: 10.1084/jem.149.4.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Di Luzio N. R. Pharmacology of the reticuloendothelial system - accent on glucan. Adv Exp Med Biol. 1976;73(PT-A):412–421. [PubMed] [Google Scholar]
  6. Di Luzio N. R., Williams D. L., McNamee R. B., Edwards B. F., Kitahama A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer. 1979 Dec 15;24(6):773–779. doi: 10.1002/ijc.2910240613. [DOI] [PubMed] [Google Scholar]
  7. Farrell J. P. Leishmania donovani: acquired resistance to visceral leishmaniasis in the golden hamster. Exp Parasitol. 1976 Aug;40(1):89–94. doi: 10.1016/0014-4894(76)90069-2. [DOI] [PubMed] [Google Scholar]
  8. Greenblatt C. L. The present and future of vaccination for cutaneous leishmaniasis. Prog Clin Biol Res. 1980;47:259–285. [PubMed] [Google Scholar]
  9. Haidaris C. G., Bonventre P. F. Elimination of Leishmania donovani amastigotes by activated macrophages. Infect Immun. 1981 Sep;33(3):918–926. doi: 10.1128/iai.33.3.918-926.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Handman E., Burgess A. W. Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages. J Immunol. 1979 Mar;122(3):1134–1137. [PubMed] [Google Scholar]
  11. Holbrook T. W., Cook J. A., Parker B. W. Glucan-enhanced immunogenicity of killed erythrocyte stages of Plasmodium berghei. Infect Immun. 1981 May;32(2):542–546. doi: 10.1128/iai.32.2.542-546.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Holbrook T. W., Cook J. A., Parker B. W. Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes. Am J Trop Med Hyg. 1981 Jul;30(4):762–768. doi: 10.4269/ajtmh.1981.30.762. [DOI] [PubMed] [Google Scholar]
  13. Kokoshis P. L., Williams D. L., Cook J. A., Di Luzio N. R. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science. 1978 Mar 24;199(4335):1340–1342. doi: 10.1126/science.628841. [DOI] [PubMed] [Google Scholar]
  14. Lemma A., Cole L. Leishmania enriettii: radiation effects and evaluation of radioattenuated organisms for vaccination. Exp Parasitol. 1974 Feb;35(1):161–169. doi: 10.1016/0014-4894(74)90019-8. [DOI] [PubMed] [Google Scholar]
  15. MANSON-BAHR P. E. Immunity in kala-azar. Trans R Soc Trop Med Hyg. 1961 Nov;55:550–555. doi: 10.1016/0035-9203(61)90078-5. [DOI] [PubMed] [Google Scholar]
  16. Reynolds J. A., Kastello M. D., Harrington D. G., Crabbs C. L., Peters C. J., Jemski J. V., Scott G. H., Di Luzio N. R. Glucan-induced enhancement of host resistance to selected infectious diseases. Infect Immun. 1980 Oct;30(1):51–57. doi: 10.1128/iai.30.1.51-57.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Spurr A. R. A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res. 1969 Jan;26(1):31–43. doi: 10.1016/s0022-5320(69)90033-1. [DOI] [PubMed] [Google Scholar]
  18. Stauber L. A. Characterization of strains of Leishmania donovani. Exp Parasitol. 1966 Feb;18(1):1–11. doi: 10.1016/0014-4894(66)90002-6. [DOI] [PubMed] [Google Scholar]
  19. Steck E. A. The leishmaniases. Prog Drug Res. 1974;18:289–351. doi: 10.1007/978-3-0348-7087-0_22. [DOI] [PubMed] [Google Scholar]
  20. Williams D. L., Cook J. A., Hoffmann E. O., Di Luzio N. R. Protective effect of glucan in experimentally induced candidiasis. J Reticuloendothel Soc. 1978 Jun;23(6):479–490. [PubMed] [Google Scholar]
  21. Williams D. L., Di Luzio N. R. Glucan-induced modification of murine viral hepatitis. Science. 1980 Apr 4;208(4439):67–69. doi: 10.1126/science.7361108. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES